Literature DB >> 641790

Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.

K J Himmelstein, I Guvenir, T F Patton.   

Abstract

A pharmacokinetic model that permits prediction of aqueous humor pilocarpine levels following topical application to rabbit eyes was developed. The model is able to account for changes in both instilled solution volume and drug concentration. The model, although simplified, relies mainly on experimentally verifiable and independently measured parameters. Its utility lies in its ability to account quantitatively for the large drainage loss of instilled drug solutions and its predictive ability regardless of the instilled volume or concentration. The framework established by this model will allow further sophistication as more experimental data become available and should be adaptable to other ophthalmic drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641790     DOI: 10.1002/jps.2600670507

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Role of P-glycoprotein in ocular clearance of rhodamine 123 in rabbits.

Authors:  T Kajikawa; H K Mishima; T Murakami; M Takano
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

Review 3.  Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.

Authors:  Abeer M Al-Ghananeem; Peter A Crooks
Journal:  Molecules       Date:  2007-03-08       Impact factor: 4.411

Review 4.  A review of the applications of physiologically based pharmacokinetic modeling.

Authors:  K J Himmelstein; R J Lutz
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

Review 5.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

6.  The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments.

Authors:  D D Tang-Liu; P J Burke
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

7.  Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.

Authors:  Maxime Le Merdy; Jianghong Fan; Michael B Bolger; Viera Lukacova; Jessica Spires; Eleftheria Tsakalozou; Vikram Patel; Lin Xu; Sharron Stewart; Ashok Chockalingam; Suresh Narayanasamy; Rodney Rouse; Murali Matta; Andrew Babiskin; Darby Kozak; Stephanie Choi; Lei Zhang; Robert Lionberger; Liang Zhao
Journal:  AAPS J       Date:  2019-05-20       Impact factor: 4.009

8.  A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits.

Authors:  S C Miller; K J Himmelstein; T F Patton
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

9.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

10.  Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.

Authors:  D S Chien; R D Schoenwald
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.